Federal inspectors documented the medication safety failures during an August 9 review, finding that licensed nurses ignored basic injection protocols for at least two residents receiving multiple daily insulin doses.
Resident 43, who has congestive heart failure, type 2 diabetes, and aphasia, received 26 insulin injections over five weeks with nurses targeting the same arm locations repeatedly. The resident's medication records show nurses injected the right upper arm six times in a row from June 30 through July 2, then switched to the left upper arm for four consecutive injections on July 3 and July 10.
The pattern continued throughout July. Nurses gave four more right upper arm injections between July 13 and July 23, followed by three left upper arm shots from July 20 to July 28. Only near the end of July did staff finally move to different injection sites on the abdomen.
Resident 211, who has type 2 diabetes with kidney complications and Alzheimer's disease, experienced similar treatment. Nurses administered insulin shots to the same abdominal quadrant multiple times in a row. On July 7, both the 7 a.m. and 11:30 a.m. doses went to the right side below the navel. Three days later, both daily injections targeted the left side below the navel.
The repetitive injection pattern continued for weeks. On July 22, nurses again chose the same right lower abdomen location for both the morning and afternoon doses. When they finally moved to a different site on July 24, they switched to the left upper arm but then gave consecutive injections there on July 25.
Registered Nurse 1 confirmed during an August 8 interview that insulin injection sites were not rotated by licensed nurses. The nurse stated this practice "could cause skin irritations such as abscess, necrosis, and lipodystrophy" and considered the failure to rotate sites "a medication error."
The Director of Nursing acknowledged that rotating insulin injection sites was "common knowledge for licensed nurses to prevent tenderness, discomfort, and lipodystrophy."
Manufacturer guidelines for both insulin types used at the facility explicitly warn against repeated injections in the same locations. The insulin lispro guidelines state that patients should "change (rotate) injection sites within the area you choose for each dose to reduce the risk of getting lipodystrophy and localized cutaneous amyloidosis."
The Novolog insulin manufacturer's recommendations go further, warning that "repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis have been reported to result in hyperglycemia." The guidelines note that "a sudden change in the injection site (to an unaffected area) has been reported to result in hypoglycemia."
These complications create dangerous scenarios for diabetic residents. When insulin absorption becomes unpredictable due to tissue damage, blood sugar levels can swing dramatically. High blood sugar episodes require immediate medical attention, while sudden drops can cause loss of consciousness or worse.
Both residents required significant daily care. Resident 43's assessment showed moderately impaired cognition and dependence on staff for toileting, bathing, and dressing. The resident needed supervision with eating and substantial assistance with most daily activities.
Resident 211's condition was even more challenging. The resident "rarely or never had the ability to make self-understood and sometimes understand others" and had severely impaired vision. Staff classified the resident as being on "high-risk drug class hypoglycemic medication."
The inspection also revealed serious equipment failures that put residents at risk for pressure injuries. Nurses improperly set specialized air mattresses designed to prevent bedsores, creating conditions that could worsen existing wounds or cause new ones.
Resident 23, who weighs 141 pounds and uses a low air loss mattress to prevent pressure injuries, had the device set to accommodate a 250-pound person. The incorrect setting made the mattress significantly firmer, defeating its protective purpose.
Licensed Vocational Nurse 2 discovered the error during the inspection and adjusted the setting to 180 pounds. The nurse explained that "when the LALM is set to a higher weight it makes the mattress harder" and "the purpose of the LALM was to provide a softer surface to prevent PIs."
Treatment Nurse 1 showed little concern about the misconfigured equipment. During an interview, the nurse said it was "not okay that the LALM was set to 250 lbs, but things happen" and claimed not to think "there was any harm in setting the LALM setting weight too high."
The nurse admitted to never consulting manufacturer guidelines for the mattresses, stating "she doesn't work for the manufacture and has never called them" and relied instead on years of facility experience.
A similar equipment failure affected Resident 230, who weighs just 79 pounds but had a low air loss mattress set for 120 pounds. The resident, who has a Stage 4 pressure ulcer at the tailbone, told inspectors the bed felt "a little uncomfortable at the buttock area when the LALM setting was at a little higher setting."
Treatment Nurse 3 acknowledged the setting should match the resident's weight and adjusted it to 80 pounds during the inspection. The Resident Assessment Coordinator confirmed that the incorrect "firmer setting for the LALM placed the resident at risk for worsening of the PU."
The facility's own policy requires staff to identify residents at risk for pressure ulcers and provide appropriate care to prevent their development. The policy specifically states that low air loss mattresses should distribute pressure over larger surface areas to reduce tissue pressure in specific locations.
Manufacturer instructions for the mattresses clearly state that users should "adjust the pressure setting to the most comfortable level without bottoming out" based on "the weight and height of the patient." The manual warns that "exceeding these limitations may result in damage to the product or personal injury."
Additional care failures emerged during the inspection. Staff left Resident 139, who has pressure injuries and uses a wheelchair, sitting in the same position for four hours without repositioning. The facility's own policy requires repositioning wheelchair-bound residents every hour and encouraging position changes every 15 minutes.
Certified Nursing Assistant 7 told inspectors "they do not reposition the resident in the wheelchair" and had kept the resident in the chair for four hours. Multiple nurses confirmed that residents should only remain in wheelchairs for a maximum of two hours to prevent skin breakdown.
The Administrator acknowledged the facility was "not following their policy and procedure" regarding wheelchair repositioning requirements.
These systematic care failures at Ararat Nursing Facility demonstrate how basic safety protocols, when ignored, can compound into serious risks for vulnerable residents who depend entirely on staff for their medical care and daily needs.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Ararat Nursing Facility from 2024-08-09 including all violations, facility responses, and corrective action plans.